A Single Ketamine Dose Could Change How We Treat Fentanyl Addiction
Fentanyl kills roughly 73,000 Americans each year. One of the most effective treatments for opioid addiction already exists. It is called buprenorphine. But many people who use fentanyl refuse to start it because the transition triggers brutal withdrawal symptoms that can last up to five days. A new study from AltaPointe Health now shows that an ultra low dose of ketamine may solve that problem entirely.
New:Â Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign Up Here
| Key Takeaway | Detail |
|---|---|
| Study size | 50 fentanyl dependent patients |
| Published | Feb. 11, 2026 in Addiction Science and Clinical Practice |
| Method | Low dose intramuscular ketamine given before buprenorphine |
| Speed of relief | Over half were symptom free within one hour |
| Facility stay reduction | Average dropped from 66 hours to 7 hours |
| Side effects | None reported |
| Cost per patient | $0.44 |
| Potential settings | ERs, outpatient clinics, prisons, mobile units, crisis centers |
Do you work in the ketamine industry? Save thousands on overhead and other fees by joining the first GPO for ketamine clinics and practitioners. There’s no cost to join and zero obligations. Sign up here!
Most clinics spend 4-6 weeks navigating Spravato REMS certification — chasing paperwork, decoding FDA requirements, and wondering if they missed a step. Our AI-powered REMS Certification Assistant cuts that to one sitting. Get a personalized checklist of exactly what you need, and walk into the REMS portal ready to submit.
Get the REMS Certification Assistant →The Buprenorphine Problem
Buprenorphine saves lives. Clinicians and researchers agree on that point. Yet fentanyl has made starting the medication far more difficult. Many patients report that buprenorphine actually worsens their withdrawal before it helps. The symptoms are severe. Muscle aches, vomiting, diarrhea, chills and intense anxiety can escalate for days. For someone already in crisis, that window of suffering is often enough to abandon treatment altogether.
How the Protocol Works
Researchers at AltaPointe’s Behavioral Health Crisis Center in Mobile, Alabama gave patients a single low dose ketamine injection before administering buprenorphine. The ketamine rapidly suppressed withdrawal symptoms at a level below what causes sedation or dissociation. Most patients then started buprenorphine with no return of symptoms and were stable enough for discharge within hours.
Dr. Luke Engeriser, who designed the study, called the approach simple, inexpensive and highly effective. The protocol builds on a 2024 pilot study led by Dr. Lucinda Grande at the University of Washington, which first demonstrated that ultra low dose ketamine could ease fentanyl withdrawal in an outpatient setting.
What This Means for Addiction Treatment
The implications extend well beyond a single crisis center in Alabama. Researchers believe this strategy could work in emergency departments, residential programs, jails and mobile clinics. Ketamine is already widely available in medical settings. At 44 cents per treatment, cost is not a barrier.
For the thousands of people trapped in fentanyl dependence who want to start recovery but fear the transition, this study offers something rare in addiction medicine: a path forward that does not require days of suffering to begin.
